XML 40 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Employee Benefits (Tables)
3 Months Ended
Mar. 31, 2023
Employee Benefits  
Schedule of plan's funded status and amounts recognized in consolidated statement of financial condition

March 31, 

December 31, 

    

2023

    

2022

Projected and accumulated benefit obligation

$

(18,037)

$

(17,138)

Plan assets at fair value

 

17,729

 

16,906

Funded status included in accrued expenses and other liabilities

$

(308)

$

(232)

Schedule of net periodic pension (benefit) cost and amounts recognized in other comprehensive income

Three months ended March 31,

    

2023

    

2022

Interest cost

$

215

$

158

Expected return on plan assets

 

(232)

 

(252)

Amortization of unrecognized loss

 

93

 

67

Net periodic cost (benefit)

$

76

$

(27)

Schedule of fair value of pension plan assets, by fair value hierarchy

The fair value of the Company’s pension plan assets, by fair value hierarchy, are as follows:

March 31, 2023

    

Level 1

    

Level 2

    

Level 3

    

Total

Assets:

Investment in separate accounts

Fixed income

$

12,015

$

$

$

12,015

Equity

 

5,714

 

 

 

5,714

Total assets at fair value

$

17,729

$

$

$

17,729

December 31, 2022

    

Level 1

    

Level 2

    

Level 3

    

Total

Assets:

Investment in separate accounts

Fixed income

$

11,600

$

$

$

11,600

Equity

 

5,306

 

 

 

5,306

Total assets at fair value

$

16,906

$

$

$

16,906

Schedule of employee stock ownership plan

March 31, 

December 31, 

2023

    

2022

Allocated

87,284

 

65,463

Committed to be allocated

5,454

 

21,821

Unallocated

343,687

 

349,141

Paid out to participants

(4,376)

(4,376)

Total shares

432,049

 

432,049

Summary of options

A summary of options under the 2020 EIP as of March 31, 2023 is presented below:

Weighted -

Weighted-Average

Number of

Average

Remaining Contractual

Shares

Exercise Price

Term (in Years)

Options outstanding at beginning of year

437,930

$

6.62

7.66

Granted

-

-

-

Exercised

-

-

-

Forfeited

(667)

6.57

-

Options outstanding at March 31, 2023

437,263

$

6.62

7.40

Options exercisable at March 31, 2023

290,126

$

6.62

7.40

Summary of Company's restricted stock activity

The following table summarizes the Company’s restricted stock activity for the three months ended March 31, 2023:

    

    

Weighted-Average

Number

Grant Date

 of Shares

Fair Value per Share

Non-vested restricted stock at beginning of year

56,266

$

6.57

Granted

-

 

-

Vested

-

 

-

Forfeited

(334)

 

6.57

Non-vested restricted stock at March 31, 2023

55,932

$

6.57